These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36700498)

  • 21. Characterization of the H-kininogen-binding site on factor XI: a comparison of factor XI and plasma prekallikrein.
    Renné T; Gailani D; Meijers JC; Müller-Esterl W
    J Biol Chem; 2002 Feb; 277(7):4892-9. PubMed ID: 11733491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factor XI, but not prekallikrein, blocks high molecular weight kininogen binding to human umbilical vein endothelial cells.
    Baird TR; Walsh PN
    J Biol Chem; 2003 Jun; 278(23):20618-23. PubMed ID: 12663668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
    Kaplan AP; Joseph K
    Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The bradykinin-forming cascade: a historical perspective.
    Kaplan AP
    Chem Immunol Allergy; 2014; 100():205-13. PubMed ID: 24925400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe high-molecular-weight kininogen deficiency due to a homozygous c.1456C > T nonsense variant in a large Chinese family.
    Yang J; Fan L; Qiao Y; Zhao Y; Zhu T
    J Thromb Thrombolysis; 2020 Nov; 50(4):989-994. PubMed ID: 32185598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on Fletcher trait and Fitzgerald trait. A rare chance to disclose body's defense reactions against injury.
    Saito H
    Thromb Haemost; 2010 Nov; 104(5):867-74. PubMed ID: 20838736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI.
    Mitropoulos KA
    Thromb Haemost; 1999 Sep; 82(3):1033-40. PubMed ID: 10494760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein.
    Wiggins RC; Bouma BN; Cochrane CG; Griffin JH
    Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4636-40. PubMed ID: 270705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on porcine high molecular weight kininogen. An improved method for the purification of porcine high molecular weight kininogen and cleavage of the kininogen by the action of porcine plasma kallikrein.
    Mashiko H; Miyamoto K; Takahashi H
    Comp Biochem Physiol B Biochem Mol Biol; 1998 Aug; 120(4):647-56. PubMed ID: 9854812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-molecular-weight kininogen cleavage correlates with disease states in the bradykinin-mediated angioedema due to hereditary C1-inhibitor deficiency.
    Suffritti C; Zanichelli A; Maggioni L; Bonanni E; Cugno M; Cicardi M
    Clin Exp Allergy; 2014 Dec; 44(12):1503-14. PubMed ID: 24552232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A renaissance for the contact system in blood coagulation?
    Blat Y; Seiffert D
    Thromb Haemost; 2008 Mar; 99(3):457-60. PubMed ID: 18327389
    [No Abstract]   [Full Text] [Related]  

  • 32. Potentiation of the function of Hageman factor fragments by high molecular weight kininogen.
    Liu CY; Scott CF; Bagdasarian A; Pierce JV; Kaplan AP; Colman RW
    J Clin Invest; 1977 Jul; 60(1):7-17. PubMed ID: 874091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mapping of the discontinuous H-kininogen binding site of plasma prekallikrein. Evidence for a critical role of apple domain-2.
    Renné T; Dedio J; Meijers JC; Chung D; Müller-Esterl W
    J Biol Chem; 1999 Sep; 274(36):25777-84. PubMed ID: 10464316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of contact activation by a kininogen peptide (HKH20) derived from domain 5.
    Nakazawa Y; Joseph K; Kaplan AP
    Int Immunopharmacol; 2002 Dec; 2(13-14):1875-85. PubMed ID: 12494915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma kallikrein/kinin system: a revised hypothesis for its activation and its physiologic contributions.
    Schmaier AH
    Curr Opin Hematol; 2000 Sep; 7(5):261-5. PubMed ID: 10961574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formation of bradykinin: a major contributor to the innate inflammatory response.
    Joseph K; Kaplan AP
    Adv Immunol; 2005; 86():159-208. PubMed ID: 15705422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective study of plasma high molecular weight kininogen and prekallikrein and incidence of coronary heart disease, ischemic stroke and heart failure.
    Parikh RR; Folsom AR; Misialek JR; Rosamond WD; Chang PP; Tang W; Cushman M
    Thromb Res; 2019 Oct; 182():89-94. PubMed ID: 31473403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-HK antibody reveals critical roles of a 20-residue HK region for Aβ-induced plasma contact system activation.
    Chen ZL; Singh PK; Horn K; Strickland S; Norris EH
    Blood Adv; 2022 May; 6(10):3090-3101. PubMed ID: 35147669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kininogen deficiency in Fitzgerald trait: role of high molecular weight kininogen in clotting and fibrinolysis.
    Donaldson VH; Glueck HI; Miller MA; Movat HZ; Habal F
    J Lab Clin Med; 1976 Feb; 87(2):327-37. PubMed ID: 1245795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antithrombotic potential of the contact activation pathway.
    Schmaier AH
    Curr Opin Hematol; 2016 Sep; 23(5):445-52. PubMed ID: 27380557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.